Simmons & Simmons Advised ArchiMed On Sale Of SuanNutra

Simmons & Simmons advised ArchiMed on the sale of SuanNutra, a nutraceutical ingredients business.

Update: 2025-12-23 11:15 GMT

Simmons & Simmons advised ArchiMed on sale of SuanNutra

The major international law firm, Simmons & Simmons advised ArchiMed on the sale of SuanNutra, the nutraceutical ingredients subsidiary of Suanfarma, 23 December 2025. The transaction involves the sale of SuanNutra, a business focused on health-enhancing food-derived products, marking its transformation into a standalone global leader in the nutraceutical ingredients sector.

ArchiMed, a private equity firm specializing in healthcare investments, acquired Suanfarma in 2021, and since then, SuanNutra has expanded significantly, reflecting ArchiMed’s strategy of building market-leading businesses.

The Simmons & Simmons team was led by Ignacio Domínguez (Partner and Head of PE/M&A, Spain), with support from Rocío Rincón (Associate, Corporate), Javier del Álamo (Associate, Corporate), Natalia Valle (HLS Regulatory Supervising Associate), Juan Sosa Pons-Sorolla (Partner, Tax), Juan Manuel Cocho (Tax Supervising Associate), Jesús Gimeno (Counsel, Employment), and a team of associates. In London, the team was primarily assisted by Lara Davies (Associate, Corporate).

Simmons & Simmons is a leading international law firm headquartered in London, founded in 1896 by twin brothers Percy and Edward Simmons. The firm operates through over 20 offices across Europe, the Middle East, Asia, and the United States, providing comprehensive legal services with a focus on highly regulated sectors and complex cross-border matters.

If you have a news or deal publication or would like to collaborate on content, columns, or article publications, connect with the Legal Era News Network Team and email us at info@legalera.in or call us on +91 8879634922.

Tags:    

Similar News